Potential type 2 diabetes mellitus drug HMPA promotes short‐chain fatty acid production by improving carbon catabolite repression effect of gut microbiota.
Saved in:
| Title: | Potential type 2 diabetes mellitus drug HMPA promotes short‐chain fatty acid production by improving carbon catabolite repression effect of gut microbiota. |
|---|---|
| Authors: | Liu, Huijuan1,2,3 (AUTHOR), Qin, Yuan1,4 (AUTHOR), Li, Kun1 (AUTHOR), Li, Meng1 (AUTHOR), Yang, Jiahuan1 (AUTHOR), Tao, Honglian1 (AUTHOR), Tang, Yuanhao1 (AUTHOR), Yang, Lan3 (AUTHOR), Chen, Shuang3 (AUTHOR), Liu, Yanrong3 (AUTHOR), Yang, Cheng1,3 (AUTHOR) cheng.yang@nankai.edu.cn, Gao, Wenqing2 (AUTHOR) gaowenqing0906@126.com, Sun, Tao1,3,5 (AUTHOR) tao.sun@nankai.edu.cn |
| Source: | British Journal of Pharmacology. Feb2021, Vol. 178 Issue 4, p946-963. 18p. 2 Color Photographs, 1 Black and White Photograph, 4 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
